NewsBenzingaVor Bio宣布:其合作伙伴荣昌生物开展的泰它西普3期数据试验显示,超过95%的参与者在48周内实现了至少5分的MG-ADL改善 Vor Bio宣布:其合作伙伴荣昌生物开展的泰它西普3期数据试验显示,超过95%的参与者在48周内实现了至少5分的MG-ADL改善 Benzinga 2026.09.29 12:07 (GMT+0) Open on Benzinga Other news AECOM Hikes Dividend, Backlog Hits Record $28 Billion Elon Musk Steps in After Jensen Huang Loses X Verification Following Nvidia Exit: ‘Blue Check Coming Back for Free on the House’ Trump Backs Howard Lutnick Amid Nvidia Row, Says Restrictions Could Have Triggered China Showdown: ‘I Understand Both Sides of It’ Nvidia Forms Board Panel for Export-Control Oversight Musk Responds to Jensen Huang's X Account Losing Blue Checkmark and Nvidia Affiliate Badge: Will Restore Blue Check for Free Amazon Cranks Up Its India Clean Energy Investment With Fresh $7 Billion Bet
Elon Musk Steps in After Jensen Huang Loses X Verification Following Nvidia Exit: ‘Blue Check Coming Back for Free on the House’
Trump Backs Howard Lutnick Amid Nvidia Row, Says Restrictions Could Have Triggered China Showdown: ‘I Understand Both Sides of It’
Musk Responds to Jensen Huang's X Account Losing Blue Checkmark and Nvidia Affiliate Badge: Will Restore Blue Check for Free